How vascular NAD(P)H oxidase activity and Nox isoform expression are regulated

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 9, 2004, Pages 1540-1541

  Yokoyama, Mitsuhiro ^a   Inoue, Nobutaka ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NOX PROTEIN; NOX1 PROTEIN; NOX3 PROTEIN; NOX4 PROTEIN; NOX5 PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CELL FUNCTION; CORONARY ARTERY BYPASS GRAFT; EDITORIAL; ENDOTHELIUM; ENZYME ACTIVITY; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; CELL COMPARTMENTATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISOENZYMES; MAMMARY ARTERIES; MICE; MULTIENZYME COMPLEXES; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; ORGAN SPECIFICITY; OXIDATIVE STRESS; SAPHENOUS VEIN;

EID: 4444251169     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000142356.48952.33     Document Type: Editorial

References (11)

1. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168-175.
2. Lassègue B, Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol. 2003;285:R277-R297.
3. Lassègue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK. Novel gp91phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced Superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88: 888-894.
4. Hilenski L, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of nox1 and nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:677-683.
5. Szöcs K, Lassègue B, Sorescu Dan, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, Griendling KK. Upregulation of nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol. 2002;22:21-27.
6. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, Itoh H, Yokoyama M. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation. 1999;100:1494-1498.
7. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: Important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol. 2002;22:1838-1844.
8. Sorescu D, Weiss D, Lassègue B, Clempus RE, Szöcs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
9. Guzik TJ, Sadowski J, Kapelak B, Jopek A, Rudzinski P, Pillai R, Korbut R, Channon KM. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol. 2004;24:1614-1620.
10. Guzik TJ, West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular Superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:e85-e90.
11. Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial Superoxide anion formation. Arterioscler Thromb Vasc Biol. 2000;20:61-69.